Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1293|16|5|297-306

ISSN： 1464-2662

Source： HIV MEDICINE, Vol.16, Iss.5, 2015-05, pp. : 297-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early treatment‐experienced subjects

By  

HIV MEDICINE, Vol. 16, Iss. 5, 2015-05 ,pp. : 288-296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study

By  

HIV MEDICINE, Vol. 19, Iss. 3, 2018-03 ,pp. : 175-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake

By  

HIV MEDICINE, Vol. 16, Iss. 10, 2015-11 ,pp. : 599-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term clinical experience with darunavir (2007–2015) in a large cohort of HIV‐infected patients in Spain

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2125-2131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data

By  

JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 30, Iss. 9, 2015-09 ,pp. : 1553-1559

John Wiley & Sons Inc

Access to resources Recommend Favorite